Ukraine drugmakers want government to revise state tendering decision

27 March 2015

Leading Ukrainian pharmaceutical producers have called on the national government to revise the earlier adopted decision to provide preferences to foreign drugmakers over local firms during the state tenders for the purchase of drugs, according to a press-service of the Ukraine government, The Pharma Letter’s local correspondent reports.

According to a recent preliminary decision of the Ukrainian government, international organizations such as the World Health Organization and UNICEF will be responsible for the organization of tenders for the purchases of drugs for state need in Ukraine.

This, however, has already sparked criticism from local drugmakers, according to which, the organization of state tenders by the WHO and UNICEF will result in the fact that the majority these contracts will be given to multinational pharmaceutical corporations, which have strong connections with the both organizations.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical